A Guilhem

1.1k total citations
42 papers, 646 citations indexed

About

A Guilhem is a scholar working on Genetics, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A Guilhem has authored 42 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 10 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A Guilhem's work include Vascular Anomalies and Treatments (11 papers), Tracheal and airway disorders (7 papers) and Bone Tissue Engineering Materials (6 papers). A Guilhem is often cited by papers focused on Vascular Anomalies and Treatments (11 papers), Tracheal and airway disorders (7 papers) and Bone Tissue Engineering Materials (6 papers). A Guilhem collaborates with scholars based in France, Belgium and United States. A Guilhem's co-authors include Patrick Frayssinet, M Gineste, Nicole Rouquet, G. Bonel, Racquel Z. LeGeros, M. Heughebaert, P Delincé, Sophie Dupuis‐Girod, Christophe Malcus and Henri Plauchu and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Biomaterials.

In The Last Decade

A Guilhem

33 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Guilhem France 10 357 268 192 109 99 42 646
Edwin C. Shors United States 14 516 1.4× 357 1.3× 252 1.3× 37 0.3× 65 0.7× 36 854
Hiroyuki Irie Japan 11 326 0.9× 242 0.9× 128 0.7× 24 0.2× 41 0.4× 32 634
Martine Melin France 11 296 0.8× 183 0.7× 236 1.2× 57 0.5× 75 0.8× 13 856
K. Würzler Germany 9 241 0.7× 154 0.6× 148 0.8× 40 0.4× 38 0.4× 11 499
Kaan Yerit Austria 15 184 0.5× 393 1.5× 381 2.0× 34 0.3× 97 1.0× 20 820
Cynthia H. Gemmell Canada 15 231 0.6× 194 0.7× 87 0.5× 38 0.3× 33 0.3× 20 877
Oliver Birke Australia 12 268 0.8× 314 1.2× 100 0.5× 41 0.4× 39 0.4× 20 653
Michael Thorwarth Germany 19 342 1.0× 392 1.5× 620 3.2× 50 0.5× 75 0.8× 42 1.1k
Ricardo Trindade Sweden 8 341 1.0× 230 0.9× 237 1.2× 29 0.3× 106 1.1× 10 655
Sylvie Bouthors France 10 406 1.1× 177 0.7× 125 0.7× 15 0.1× 79 0.8× 16 649

Countries citing papers authored by A Guilhem

Since Specialization
Citations

This map shows the geographic impact of A Guilhem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Guilhem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Guilhem more than expected).

Fields of papers citing papers by A Guilhem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Guilhem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Guilhem. The network helps show where A Guilhem may publish in the future.

Co-authorship network of co-authors of A Guilhem

This figure shows the co-authorship network connecting the top 25 collaborators of A Guilhem. A scholar is included among the top collaborators of A Guilhem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Guilhem. A Guilhem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kjeldsen, Anette Drøhse, Annette Dam Fialla, A Guilhem, et al.. (2025). Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres. British Journal of Clinical Pharmacology. 92(2). 535–544.
2.
Dupuis‐Girod, Sophie, Évelyne Decullier, Sophie Rivière, et al.. (2025). BEST study: one-year descriptive follow-up of bevacizumab treatment in hereditary haemorrhagic telangiectasia post-BABH interventional study. Therapeutic Advances in Hematology. 16. 1574218588–1574218588.
3.
Proust, Carole, A Guilhem, Aurélie Goyenvalle, et al.. (2025). Overlapping upstream ORFs ending at c.125 lead to reduced Endoglin, contributing to Hereditary Hemorrhagic Telangiectasia. Communications Biology. 8(1). 1072–1072. 1 indexed citations
4.
Tusseau, Maud, Mélanie Eyries, Nicolas Chatron, et al.. (2024). Genome sequencing identify chromosome 9 inversions disrupting ENG in 2 unrelated HHT families. European Journal of Medical Genetics. 68. 104919–104919. 3 indexed citations
5.
Guilhem, A, et al.. (2024). Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances. Journal of Clinical Investigation. 134(4). 21 indexed citations
6.
Guilhem, A, Sophie Dupuis‐Girod, Olivier Espitia, et al.. (2023). Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with EPHB4 pathogenic variants. Journal of Medical Genetics. 60(9). 905–909. 2 indexed citations
7.
Samson, M., Barbara Nicolas, Marion Ciudad, et al.. (2022). T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients. European Journal of Internal Medicine. 102. 104–109. 5 indexed citations
8.
Blot, Mathieu, Jean‐Baptiste Bour, Jean‐Pierre Quenot, et al.. (2021). The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome (vol 18, 457, 2020). Journal of Translational Medicine. 19(1). 2–2. 1 indexed citations
9.
Blot, Mathieu, Jean‐Baptiste Bour, Jean‐Pierre Quenot, et al.. (2021). Correction to: The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome. Journal of Translational Medicine. 19(1). 100–100. 5 indexed citations
10.
Guilhem, A, Pierre Portalès, Sophie Dupuis‐Girod, Sophie Rivière, & Thierry Vincent. (2021). Altered expressions of CXCR4 and CD26 on T-helper lymphocytes in hereditary hemorrhagic telangiectasia. Orphanet Journal of Rare Diseases. 16(1). 511–511. 1 indexed citations
11.
Samson, M., A Guilhem, V. Leguy‐Seguin, et al.. (2017). Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients. PLoS ONE. 12(10). e0187296–e0187296. 16 indexed citations
12.
Maillet, Thibault, V. Leguy‐Seguin, M. Samson, et al.. (2016). Pseudotumeur rénale : une forme trompeuse de maladie associée aux IgG4. La Revue de Médecine Interne. 37. A206–A207.
13.
Guilhem, A, et al.. (2010). Pneumopathie post-radique aiguë : une pneumopathie rare, potentiellement grave et très corticosensible. La Revue de Médecine Interne. 31(8). e10–e12. 1 indexed citations
14.
Gineste, M, et al.. (1999). Degradation of hydroxylapatite, fluorapatite, and fluorhydroxyapatite coatings of dental implants in dogs. Journal of Biomedical Materials Research. 48(3). 224–234. 151 indexed citations
15.
Guilhem, A, et al.. (1996). [PUNCTURE BIOPSY OF THE KIDNEY IN THE RENO-VASCULAR SYNDROMES OF PREGNANCY. 3. HISTOCHEMICAL STUDY OF RENAL BIOPSIES IN THE COMPLICATIONS OF PREGNANCY. PATHOGENIC INTERPRETATION].. PubMed. 64. 145–57.
16.
Frayssinet, Patrick, D. Hardy, Nicole Rouquet, et al.. (1992). New observations on middle term hydroxyapatite-coated titanium alloy hip prostheses. Biomaterials. 13(10). 668–674. 34 indexed citations
17.
Heughebaert, M., Racquel Z. LeGeros, M Gineste, A Guilhem, & G. Bonel. (1988). Physicochemical characterization of deposits associated with HA ceramics implanted in nonosseous sites. Journal of Biomedical Materials Research. 22(S14). 257–268. 129 indexed citations
18.
Marquès, Bernard, et al.. (1979). [Action of thymic extracts on the growth of different cell populations in vitro].. PubMed. 63(182). 273–85.
19.
Guilhem, A, et al.. (1966). Maladie de Dupont et Lachapelle (thésaurismose cutanée par polyvinylpyrrolidone). 22(4). 3 indexed citations
20.
Guilhem, A, et al.. (1962). [Existence in the circulating blood of a variety of lymphocyte presenting a non-specific esterase activity and a colloidopexic capacity].. PubMed. 254. 1696–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edwin C. Shors Breakdown of academic impact, for papers by Hiroyuki Irie Breakdown of academic impact, for papers by Martine Melin Breakdown of academic impact, for papers by K. Würzler Breakdown of academic impact, for papers by Kaan Yerit Breakdown of academic impact, for papers by Cynthia H. Gemmell Breakdown of academic impact, for papers by Oliver Birke Breakdown of academic impact, for papers by Michael Thorwarth Breakdown of academic impact, for papers by Ricardo Trindade Breakdown of academic impact, for papers by Sylvie Bouthors
Rankless by CCL
2026